295 related articles for article (PubMed ID: 15052371)
21. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
22. [Body composition in Negro African children suffering from sickle cell disease. A mixed cross-sectional longitudinal study in Brazzaville, Congo].
Mabiala-Babela JR; Massamba A; Tsiba JB; Moulongo JG; Nzingoula S; Senga P
Bull Soc Pathol Exot; 2005 Dec; 98(5):394-9. PubMed ID: 16425723
[TBL] [Abstract][Full Text] [Related]
23. Platelet P-selectin and platelet mass, volume and component in sickle cell disease: relationship to genotype.
Mohan JS; Lip GY; Bareford D; Blann AD
Thromb Res; 2006; 117(6):623-9. PubMed ID: 16051315
[TBL] [Abstract][Full Text] [Related]
24. [Vaso-occlusive crisis of sickle cell child in Brazzaville drugs news].
Mbika Cardorelle A; Okoko A; Mouko A
Arch Pediatr; 2010 Mar; 17(3):295-6. PubMed ID: 20034770
[No Abstract] [Full Text] [Related]
25. Low bone mass due to sickle cell anemia: is it becoming a real issue?
Sadat-Ali M; Al-Elq AH; Sultan O; Al-Turki H; Bukhari R; Al-Mulhim E
West Afr J Med; 2008 Oct; 27(4):218-23. PubMed ID: 19469399
[TBL] [Abstract][Full Text] [Related]
26. Studies on the management and prevention of vasoocclusive crisis in sickle cell disease.
Ambrus JL; Ambrus CM; Bannerman R; Sills RH; Meky NN
J Med; 1984; 15(5-6):385-407. PubMed ID: 6100377
[TBL] [Abstract][Full Text] [Related]
27. Comparison of clinical, hematological and molecular findings of Jamaican and Sicilian patients with sickle cell disease.
Schiliro G; Russo Mancuso G; Kulozik AE; Serjeant BE; Serjeant GR
Haematologica; 1990; 75 Suppl 5():42-56. PubMed ID: 2086381
[No Abstract] [Full Text] [Related]
28. Hematology Problem.
LeCrone C; Jones J; Detter J
Am J Med Technol; 1980 Sep; 46(9):668-9. PubMed ID: 6158267
[No Abstract] [Full Text] [Related]
29. Orbital infarction in sickle cell disease.
Ganesh A; Al-Zuhaibi S; Pathare A; William R; Al-Senawi R; Al-Mujaini A; Hussain S; Wali Y; Alkindi S; Zachariah M; Knox-Macaulay H
Am J Ophthalmol; 2008 Oct; 146(4):595-601. PubMed ID: 18662809
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.
Hijazi Z; Onadeko BO; Khadadah M; Haider MZ; Adekile AD; Al-Habashi H
Int J Clin Pract; 2005 Feb; 59(2):163-7. PubMed ID: 15854191
[TBL] [Abstract][Full Text] [Related]
31. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
32. Are there phases to the vaso-occlusive painful episode in sickle cell disease?
Jacob E; Beyer JE; Miaskowski C; Savedra M; Treadwell M; Styles L
J Pain Symptom Manage; 2005 Apr; 29(4):392-400. PubMed ID: 15857743
[TBL] [Abstract][Full Text] [Related]
33. Study of platelet function in patients with sickle cell anemia during steady state and vaso-occlusive crisis.
Papadimitriou CA; Travlou A; Kalos A; Douratsos D; Lali P
Acta Haematol; 1993; 89(4):180-3. PubMed ID: 8212998
[TBL] [Abstract][Full Text] [Related]
34. Modulation of erythroid adhesion receptor expression by hydroxyurea in children with sickle cell disease.
Odièvre MH; Bony V; Benkerrou M; Lapouméroulie C; Alberti C; Ducrocq R; Jacqz-Aigrain E; Elion J; Cartron JP
Haematologica; 2008 Apr; 93(4):502-10. PubMed ID: 18322255
[TBL] [Abstract][Full Text] [Related]
35. Sickle cell disease; a general overview.
Schnog JB; Duits AJ; Muskiet FA; ten Cate H; Rojer RA; Brandjes DP
Neth J Med; 2004 Nov; 62(10):364-74. PubMed ID: 15683091
[TBL] [Abstract][Full Text] [Related]
36. The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease.
Pawar SS; Panepinto JA; Brousseau DC
Pediatr Blood Cancer; 2008 Jan; 50(1):111-3. PubMed ID: 16619223
[TBL] [Abstract][Full Text] [Related]
37. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.
Panepinto JA; Brousseau DC; Hillery CA; Scott JP
Pediatr Blood Cancer; 2005 Feb; 44(2):182-6. PubMed ID: 15390359
[TBL] [Abstract][Full Text] [Related]
38. Sickle cell disease in children: differentiating osteomyelitis from vaso-occlusive crisis.
Berger E; Saunders N; Wang L; Friedman JN
Arch Pediatr Adolesc Med; 2009 Mar; 163(3):251-5. PubMed ID: 19255393
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary complications of sickle cell disease in children.
Caboot JB; Allen JL
Curr Opin Pediatr; 2008 Jun; 20(3):279-87. PubMed ID: 18475096
[TBL] [Abstract][Full Text] [Related]
40. Platelet count and platelet factor 3 (PF-3) availability in sickle cell disease.
Famodu AA; Oduwa D
Br J Biomed Sci; 1995 Dec; 52(4):323-4. PubMed ID: 8555788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
